Thirdly, related drugs that are also used for the treatment of CML but do not inhibit the SIKs, such as imatinib, fail to induce CREB-dependent gene transcription and to elevate IL-10 production in macrophages. Here, CREB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.